Tina Susan Nova
CIK 1302605 · Executive Chairperson · last filed 2026-06-08
Tina Susan Nova is an Executive Chairperson who has filed 82 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for AUPH, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$10.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.00M
9
82
-$10.18M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Director | — | $15.82 | — | $0 | 2 | 2026-06-08 |
| AZTA | Director | 15,772 | $22.59 | $356.3K | $0 | 4 | 2026-02-06 |
| XGN | Executive Chairperson | — | $4.67 | — | $0 | 7 | 2025-06-12 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Director | 0 | $99.99 | $0 | -$1.23M | 18 | 2022-03-11 |
| VCYT | President, CLIA U.S. | 76,988 | $47.33 | $3.64M | $0 | 8 | 2022-03-07 |
| OPGEN INC (OPGNW) Delisted | Director | 750 | — | — | $0 | 4 | 2019-09-03 |
| GENOPTIX INC (GXDX) Delisted | President and CEO | 25 | — | — | -$8.95M | 29 | 2011-03-07 |
| CYPRESS BIOSCIENCE INC (CYPB) Delisted | Director | — | — | — | $0 | 1 | 2010-01-06 |
| CYPRESS BIOSCIENCE INC (NSTR) Delisted | Director | — | — | — | $0 | 4 | 2009-01-07 |
Recent Filings
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2026-02-06 | AZTA | Grant (A) | +5,663 | $157.7K | EDGAR |
| 2025-06-12 | XGN | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2025-02-11 | AZTA | Grant (A) | +4,040 | $211.4K | EDGAR |
| 2024-06-12 | XGN | Grant (A) | — | $0 | EDGAR |
| 2024-02-13 | AZTA | Grant (A) | −2,465 | -$162.5K | EDGAR |
| 2023-06-20 | XGN | Grant (A) | — | $0 | EDGAR |
| 2023-02-15 | AZTA | Grant (A) | +3,604 | $0 | EDGAR |
| 2022-06-21 | XGN | Grant (A) | — | $0 | EDGAR |